ARRC ARMOUR Pfd C posts neutral quarterly earnings with no surprises and steady preferred payout expectations Phillips 66 PSX Navigating Crude Volatility Refining Strength Offsets Hedging Headwinds Amid Geopolitical Tensions Live LYV vs Competition Live misses Q4 EPS estimates by 4 as loss widens How BioLineRx BLRX balances growth with profitability Strengthens 20260503 MYO Myomo posts narrow Q4 2025 EPS beat shares rise 552 percent on positive investor sentiment PASW Ping An posts solid quarterly biomedical segment growth as new diagnostic lines gain strong clinical adoption GERN Geron Corporation posts narrower Q4 2025 loss than analyst estimates shares rise 26 percent on positive investor sentiment NPCT Nuveen quarterly earnings details remain undisclosed investors await updates on its impact fund portfolio performance The RD spending story behind Instil Bio TIL innovation Instil Bio posts 41 EPS beat narrower loss no revenue What Caribou Bio CRBU is doing that smarter investors notice Q4 2025 EPS Tops Views